Cleveland BioLabs and Incuron Announce Poster Presentation at Cell Symposia: Cancer Epigenomics
October 02, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster...
Cleveland BioLabs Secures $10 Million Loan Agreement With Hercules Technology Growth Capital
October 01, 2013 08:36 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) announced today it has closed on a loan and security agreement with Hercules Technology Growth Capital, Inc....
Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 European Cancer Congress
September 19, 2013 08:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Sept. 19, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster...
Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 ASCP Annual Meeting
September 12, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster...
Cleveland BioLabs Reports Second Quarter 2013 Financial Results and Development Progress
August 13, 2013 07:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the second quarter and six-month periods ended June...
Cleveland BioLabs and Incuron Announce Start of US Trial With CBL0137
August 07, 2013 08:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced that a...
Cleveland BioLabs to Report Second Quarter 2013 Financial Results and Provide Operational Update on August 13
August 01, 2013 08:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that on August 13, 2013 before the market opens, it will report its financial results for the...
Cell Reports Publication Elucidates Role of FACT as Accelerator of Tumor Transformation and Potential Marker and Target of Aggressive Cancers
July 08, 2013 07:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., July 8, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI), Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, and Roswell Park Cancer Institute...
Cleveland BioLabs and Incuron Announce Poster Presentation at ESMO 15th World Congress on Gastrointestinal Cancer
June 25, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., June 25, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, today announced a poster...
Cleveland BioLabs and Incuron Announce US and European Patent Allowances for Curaxins
May 14, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., May 14, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced the receipt...